AMPH
AMPH
Positions held
Your positionsAMPH isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · 1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges
2026-10-06 · Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
2026-10-01 · 3 Stocks Under $50 We Think Twice About
2026-09-24 · 3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
2026-09-21 · 3 Russell 2000 Stocks We Find Risky
2026-09-18 · 3 Small-Cap Stocks with Warning Signs
2026-09-17 · Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group
2026-09-06 · Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
2026-09-05 · Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
2026-09-01 · 3 Healthcare Stocks We Keep Off Our Radar
2026-09-01 · Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
2026-08-31 · Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris
Price (daily)
Full chart · RSI · MACD · patterns